LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway

被引：15
|
作者：
Li, Jiandong [1 ]
Xu, Xiaohu [1 ]
Zhang, Dandan [1 ]
Lv, Han [1 ]
Lei, Xin [1 ]
机构：
[1] Shenzhen Longhua Dist Cent Hosp, Dept Stomatol, Shenzhen 518000, Peoples R China
来源：
ONCOTARGETS AND THERAPY | 2021年 / 14卷
关键词：
oral squamous cell carcinoma; LHFPL3-AS1; miR-362-5p; CHSY1; CANCER METASTASIS; PROLIFERATION; INVASION; AXIS;
D O I：
10.2147/OTT.S298679
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background: Oral squamous cell carcinoma (OSCC) is a common oral cancer. The current study aims to elucidate the potential roles of long noncoding RNA (lncRNA) LHFPL3-AS1 in OSCC development. Methods: Gene expression was measured by qRT-PCR in tumor tissues and cell lines. Loss-of-function assays were performed to analyze the effects of LHFPL3-AS1 on malignant behaviors. Bioinformatics analysis was conducted to explore the downstream signaling pathway of LHFPL3-AS1 in OSCC. Results: LHFPL3-AS1 was highly expressed in OSCC tissues and cell lines. LHFPL3-AS1 was upregulated in cisplatin-resistant tumor cell lines. LHFPL3-AS1 level was correlated with survival rate. LHFPL3-AS1 knockdown suppressed OSCC proliferation, migration and invasion. LHFPL3-AS1 downregulation reduced cisplatin resistance of OSCC cells. LHFPL3-AS1 was the competing endogenous RNA (ceRNA) for miR-194-5p to enhance CHSY1 expression. Conclusion: LHFPL3-AS1/miR-362-5p/CHSY1 signaling pathway plays essential roles in regulating OSCC development and cisplatin resistance.
引用
收藏
页码：2293 / 2300
页数：8
相关论文
共 50 条
  • [31] LncRNA PAPAS promotes oral squamous cell carcinoma by upregulating transforming growth factor-β1
    Zhang, Panpan
    Liu, Ying
    Li, Chong
    Zhang, Li
    Liu, Qing
    Jiang, Tao
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (09) : 16120 - 16127
  • [32] lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5
    Jiang, Yingying
    Guo, Haiyan
    Tong, Tong
    Xie, Fei
    Qin, Xing
    Wang, Xiaoning
    Chen, Wantao
    Zhang, Jianjun
    MOLECULAR THERAPY, 2022, 30 (01) : 448 - 467
  • [33] lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p
    Yang, Shuo
    Yuan, Zhi-Jun
    Zhu, Yue-Hong
    Chen, Xue
    Wang, Wei
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (09): : 2712 - 2723
  • [34] Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma: Erratum
    Song, An
    Wu, Yuanyuan
    Chu, Weiming
    Yang, Xueming
    Zhu, Zaiou
    Yan, Enshi
    Zhang, Wei
    Zhou, Junbo
    Ding, Xu
    Liu, Jie
    Zhu, Hongxia
    Ye, Jinhai
    Wu, Yunong
    Zheng, Yang
    Song, Xiaomeng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (05): : 1705 - 1706
  • [35] Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis
    Hu, Tao
    Niu, Yunfeng
    Fu, Jianfeng
    Dong, Zhiming
    He, Dongwei
    Liu, Junfeng
    OPEN MEDICINE, 2022, 17 (01): : 1483 - 1494
  • [36] A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
    Wang, Yufeng
    Yang, Liu
    Chen, Tianxiang
    Liu, Xin
    Guo, Yang
    Zhu, Qiaojuan
    Tong, Xiangmin
    Yang, Wei
    Xu, Qiuran
    Huang, Dongsheng
    Tu, Kangsheng
    MOLECULAR CANCER, 2019, 18 (1)
  • [37] A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
    Yufeng Wang
    Liu Yang
    Tianxiang Chen
    Xin Liu
    Yang Guo
    Qiaojuan Zhu
    Xiangmin Tong
    Wei Yang
    Qiuran Xu
    Dongsheng Huang
    Kangsheng Tu
    Molecular Cancer, 18
  • [38] hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma
    Lin, Xiu-Juan
    He, Chang-Li
    Sun, Ting
    Duan, Xue-Jing
    Sun, Yi
    Xiong, Shi-Jiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 (01) : 83 - 89
  • [39] LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway
    Ye, J.
    Jiao, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (13) : 5779 - 5786
  • [40] MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway
    Zhou, Y.
    Xu, X. M.
    Feng, Y.
    NEOPLASMA, 2020, 67 (03) : 528 - +
12345